about
Calcium and phosphate impact cardiovascular risk.Relationship between Fibroblast Growth Factor 23 and Biochemical and Bone Histomorphometric Alterations in a Chronic Kidney Disease Rat Model Undergoing ParathyroidectomyRelationship between Fibroblast Growth Factor-23 and Mineral Metabolism in Chronic Kidney DiseaseCinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled studyRenal function, calcium regulation, and time to hospitalization of patients with chronic kidney disease.Renal expression of FGF23 in progressive renal disease of diabetes and the effect of ACE inhibitorFGF23 neutralization improves bone quality and osseointegration of titanium implants in chronic kidney disease mice.Fibroblast growth factor 23 predicts left ventricular mass and induces cell adhesion molecule formationFGF-23 dysregulates calcium homeostasis and electrophysiological properties in HL-1 atrial cells.Associations of fibroblast growth factor-23 with markers of inflammation, insulin resistance and obesity in adultsFibroblast growth factor-23-mediated inhibition of renal phosphate transport in mice requires sodium-hydrogen exchanger regulatory factor-1 (NHERF-1) and synergizes with parathyroid hormone.Phosphate may promote CKD progression and attenuate renoprotective effect of ACE inhibition.Cardiorenal syndrome and vitamin D receptor activation in chronic kidney diseaseHigh Fibroblast Growth Factor 23 Levels Associated With Low Hemoglobin Levels in Patients With Chronic Kidney Disease Stages 3 and 4.Mineral metabolic abnormalities and mortality in dialysis patients.Single FGF-23 measurement and time-averaged plasma phosphate levels in hemodialysis patients.Fibroblast growth factor 23 in chronic kidney disease: New insights and clinical implications.Mineral metabolism and vitamin D in chronic kidney disease--more questions than answers.Cardiovascular disease in chronic kidney disease: untying the Gordian knot.Calcitriol, calcidiol, parathyroid hormone, and fibroblast growth factor-23 interactions in chronic kidney disease.Renal biomarkers in domestic species.FGF-23 and PTH levels in patients with acute kidney injury: A cross-sectional case series study.Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients.Model-Based Analysis of FGF23 Regulation in Chronic Kidney Disease.The Association between Fibroblast Growth Factor-23 and Vascular Calcification Is Mitigated by Inflammation MarkersPhosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients.Baseline FGF23 is Associated with Cardiovascular Outcome in Incident PD Patients.FGF-23 levels are associated with vascular calcification, but not with atherosclerosis, in hemodialysis patients.Fibroblast growth factor-23 levels are associated with vascular calcifications in peritoneal dialysis patients.
P2860
Q27687570-383F8E15-1354-490B-98AD-BE974FB22B17Q28546638-94EEB2AD-4087-4FF5-BFE6-8B5FDDD92CAEQ34479134-E0400587-4AF8-4C20-BB4C-28CF8EE2CF59Q34739121-66368DDB-F8B4-45F5-8B6F-240028421FDCQ34831535-1B885DC8-4D05-4025-961E-F9D6917AC6F3Q34962806-FEDA7282-B0E9-4C69-A102-FAAD85BE702CQ35065731-D4D41ED4-4238-4CE6-A728-1467D4031F45Q35157648-DD7B14B6-E6DC-4910-958A-C37AC162A286Q35190689-D934FF1E-BA4F-4F37-B359-3299E381599DQ35220170-BA82F1E9-F08D-4644-B1F4-0BC66AF8C63BQ35423514-84C9406E-7FD9-4D2B-861C-55B8DB251F28Q35758311-12D5DD4E-D5DC-486D-91B4-DD657DE1965AQ36468531-DB7E1374-B77D-4B33-B0B1-64EF2E408B2CQ36822751-9A517A09-D111-4252-AF5B-F427B5463899Q36994038-9D1B4886-E8EA-471C-89B1-EF8EC981E443Q37212400-60971C56-B6AA-4AA6-A839-B74C2C213FF5Q37832285-7ABE1740-E385-40DC-89CD-30639149485FQ37871341-DF89D981-45B3-46F2-8551-8769B1E75073Q38025185-94F9DD4E-7027-414B-A8A2-3AA6110B881CQ38097111-DF25E927-0CF8-40CF-9D57-F4DC89264344Q38751246-FE5D88CB-9976-4F61-A9D8-CB876EDBCC46Q39387561-084CBCD9-CE7D-4620-AA12-B189B15F4CBAQ40846380-7FC3AC69-93CB-4647-BD46-34F150797FE4Q42735168-B33F171C-A3DB-4223-8FF0-9979FD1F6AB0Q42860478-65A02C91-EB61-48BE-A802-3D75F1A56A7CQ44204313-C6890672-171F-4EDA-973A-DBE333910FE0Q50636871-6411C7C6-AC13-4F41-80C3-9755574905B5Q52985054-21B213C1-5D7B-4433-83D2-3F9243151123Q54700038-8F21BFD4-916C-4882-807D-8962288E4A28
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical relevance of FGF-23 in chronic kidney disease.
@en
Clinical relevance of FGF-23 in chronic kidney disease.
@nl
type
label
Clinical relevance of FGF-23 in chronic kidney disease.
@en
Clinical relevance of FGF-23 in chronic kidney disease.
@nl
prefLabel
Clinical relevance of FGF-23 in chronic kidney disease.
@en
Clinical relevance of FGF-23 in chronic kidney disease.
@nl
P2093
P356
P1476
Clinical relevance of FGF-23 in chronic kidney disease.
@en
P2093
Danilo Fliser
Gunnar H Heine
Sarah Seiler
P304
P356
10.1038/KI.2009.405
P577
2009-12-01T00:00:00Z